Patient-derived organoids (PDOs) provide greater translational relevance than conventional cell lines by more accurately reflecting key structural, functional, and genetic features of human tissues. Their ability to reproduce these characteristics makes them a valuable resource for primary research, drug development, and gaining insight into disease mechanisms.
This eBook looks at the practical challenges of implementing PDO models at scale, with a focus on maintaining consistent, high-quality models while reducing the amount of manual work required and controlling overall costs.
About Molecular Devices UK Ltd
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.